PDCD1 and neoplasm: For example, iPSC-derived NK cells combined with anti-PD-1 therapy showed synergistic effects in ovarian cancer, delaying tumour progression and enhancing T cell recruitment and inflammatory cytokine production, transforming a “cold” TME into a “hot” TME (70).